EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease

Yao Dong, Zhonghui Gai, Mei Han, Jiaqi Xu, Kang Zou

Probiotics and Antimicrobial Proteins · 2025

DOI: 10.1007/s12602-024-10293-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Yao Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Germline Stem Cells and Microenvironment Lab, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Renal Insufficiency, Chronic, Uremic Toxins, Probiotics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota dysbiosis and consequent impairment of gut barrier function, culminating in elevated levels of uremic toxins, are prevalent in chronic kidney disease (CKD) patients. These toxins, notably indoxyl sulphate (IS), indole-3-acetic acid (IAA), and trimethylamine oxide (TMAO), are implicated in a spectrum of CKD-related complications, including cardiovascular disease, bone and mineral disorders, and inflammation. The specific impacts of various probiotics on these CKD manifestations remain unexplored. This study delved into the potential of dietary probiotic interventions, particularly Bifidobacterium longum subsp. longum BL21, to modulate gut microbiota and mitigate metabolic disorders in a CKD rat model. Over a six-week period, we administered a dietary regimen of BL21 and conducted comprehensive analyses, including serum uremic toxin quantification and 16S rRNA gene sequencing, to systematically profile gut microbial alterations at the phylogenetic level. Our findings reveal that BL21 intervention significantly ameliorated CKD-induced disruptions in gut microbial populations, enhancing both microbial richness and the relative abundance of key taxa. Importantly, BL21 appeared to exert its beneficial effects by modulating the abundance of crucial species such as Barnesiella and Helicobacter . Functionally, the intervention markedly normalized serum levels of IS, IAA, and TMAO, while potentially attenuating p-cresol sulphate (PCS) and p-cresol glucuronide (PCG) concentrations. Consequently, BL21 demonstrated efficacy in regulating gut microbiota and curtailing the accumulation of uremic toxins. Our results advocate for the utilization of BL21 as a dietary intervention to diminish serum uremic toxins and re-establish gut microbiota equilibrium at the phylogenetic level, underscoring the promise of probiotic strategies in the management of CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeRenal Insufficiency, ChronicUremic ToxinsProbioticsBifidobacterium longumAnimalsRatsMaleDisease Models, AnimalRats, Sprague-DawleyIndicanIndoleacetic Acids

Stichwörter der Autor:innen

Bifidobacterium longum subsp. longumChronic kidney diseaseGut microbiota dysbiosisProbiotic interventionUremic toxins

Substanzen

Uremic ToxinsIndicanindoleacetic acidIndoleacetic Acids

Autor:innen und Institutionen

  • Germline Stem Cells and Microenvironment Lab, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.
  • Stem Cell Research and Translation Center, Nanjing Agricultural University, Nanjing, 210095, China.
  • Department of Research and Development, Wecare Probiotics Co., Ltd, Suzhou, 215200, China.
  • Department of Food Quality and Safety, Shanghai Business School, Shanghai, 200235, China.
  • Germline Stem Cells and Microenvironment Lab, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China. Kangzou@njau.edu.cn.
  • Stem Cell Research and Translation Center, Nanjing Agricultural University, Nanjing, 210095, China. Kangzou@njau.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Dong, Y., Gai, Z., Han, M., Xu, J., & Zou, K. (2025). Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-024-10293-5

Vancouver

Dong Y, Gai Z, Han M, Xu J, Zou K. Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-024-10293-5

BibTeX
@article{Dong2025,
  author = {Dong, Yao and Gai, Zhonghui and Han, Mei and Xu, Jiaqi and Zou, Kang},
  title = {Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  doi = {10.1007/s12602-024-10293-5}
}
Kostenlos starten →